Focusing on the early
stages of amyotrophic lateral sclerosis may be key to treating it, study suggests.
Not exact matches
In summary, we demonstrate similar neurological / motor function deficits in SOD1 and PFN1 mice, both exhibiting clinically - relevant attributes
of Amyotrophic lateral sclerosis (ALS), with more advanced computer vision systems identifying distinctive behavioral patterns and discriminating the phenotype at very early disease
stages in both models.
& Cambridge, MA About Blog ProMIS ™ Neurosciences, Inc., is a development
stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment
of neurodegenerative diseases, in particular Alzheimer's disease (AD) and
amyotrophic lateral sclerosis (ALS).
& Cambridge, MA About Blog ProMIS ™ Neurosciences, Inc., is a development
stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment
of neurodegenerative diseases, in particular Alzheimer's disease (AD) and
amyotrophic lateral sclerosis (ALS).
& Cambridge, MA About Blog ProMIS ™ Neurosciences, Inc., is a development
stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment
of neurodegenerative diseases, in particular Alzheimer's disease (AD) and
amyotrophic lateral sclerosis (ALS).